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Summary
 
In the mouse embryo, the generation of candidate progenitors for long-lasting hemopoiesis has
been reported in the paraaortic splanchnopleura (P-Sp)/aorta-gonad-mesonephros (AGM) re-
gion. Here, we address the following question: can the P-Sp/AGM environment support hemo-
poietic differentiation as well as generate stem cells, and, conversely, are other sites where hemo-
poietic differentiation occurs capable of generating stem cells? Although P-Sp/AGM generates
de novo hemopoietic stem cells between 9.5 and 12.5 days post coitus (dpc), we show here that
it does not support hemopoietic differentiation. Among mesoderm-derived sites, spleen and
omentum were shown to be colonized by exogenous cells in the same fashion as the fetal liver.
Cells colonizing the spleen were multipotent and pursued their evolution to committed pro-
genitors in this organ. In contrast, the omentum, which was colonized by lymphoid-commit-
ted progenitors that did not expand, cannot be considered as a hemopoietic organ. From these
data, stem cell generation appears incompatible with hemopoietic activity. At the peak of hemo-
poietic progenitor production in the P-Sp/AGM, between 10.5 and 11.5 dpc, multipotent
cells were found at the exceptional frequency of 1 out of 12 total cells and 1 out of 4 AA4.1
 
1
 
cells. Thus, progenitors within this region constitute a pool of undifferentiated hemopoietic cells
readily accessible for characterization.
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D
 
uring ontogeny, it is intriguing that apart from the
yolk sac (YS),
 
1
 
 which both produces hemopoietic pro-
genitors and carries out erythropoiesis, other organs where
active hemopoiesis takes place, such as the thymus and fetal
liver, must be colonized by extrinsic hemopoietic stem cells
(HSCs) or progenitors (1–3). Here we attempted to under-
stand the constraints affecting these processes by establish-
ing how far progenitors generated in the paraaortic splanch-
nopleura (P-Sp)/aorta-gonad-mesonephros (AGM) region
could evolve in situ, and by determining whether the spleen
and omentum, i.e., mesodermal structures derived from the
P-Sp, have a similar or different capacity in this regard.
We have previously demonstrated that, before circula-
tion is established, progenitors emerging in the intraembry-
onic splanchnic mesoderm are capable of generating all
hemopoietic lineages (4). In contrast, YS progenitors have
a restricted proliferative capacity and yield erythromyeloid
cells (4). Altogether, the results indicate that the colonizing
multipotent cells come from the embryo proper, from the
region comprising the aorta and the mesodermal territory
where the genital ridges and mesonephros later develop. It
has been called P-Sp at the stages of 15–25S (8.5–9.5 days
post coitus [dpc]; reference 5) and AGM thereafter (6, 7).
After the establishment of blood circulation (5–8S, 8 dpc),
multipotent cells can be found in the blood vessels and col-
onize the hemopoietic rudiments (5–8).
Here we analyzed the differentiation potential of hemo-
poietic cells in the P-Sp/AGM. We failed to detect pro-
genitors committed to specific lineages, as ascertained by
single cell analysis and by the absence of committed ery-
throid colony-forming precursors. Thus, cells within this re-
gion remain essentially multipotent. The quantification of
progenitors by limiting dilution assays showed a continuous
production starting by 9 dpc in the P-Sp and becoming
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Abbreviations used in this paper:
 
 
 
AGM, aorta-gonad-mesonephros; BFU-E,
burst-forming unit–erythroid; CFC, colony-forming cell; CFU-S, colony-
forming unit–splenic; dpc, day(s) post coitus; Epo, erythropoietin; FTOC,
 
fetal thymic organ culture; HSC, hemopoietic stem cell; KL, c-Kit ligand;
LTR, long-term reconstitution; PeC, peritoneal cavity; P-Sp, paraaortic
splanchnopleura; YS, yolk sac. 
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completely extinguished by 13 dpc in the AGM, with a
peak at 
 
z
 
11 dpc. Finally, within the AGM, hemopoietic
progenitors were found concentrated in the aorta and sur-
rounding mesenchymal cells.
There is a paradox in the embryogenesis of the hemo-
poietic system which is as follows: contact with endoderm
appears necessary for the emergence of hemopoietic progen-
itors (9–11), yet hemopoietic organ rudiments that are con-
stituted of mesoderm and endoderm, such as the thymus and
liver, do not give rise to hemopoietic progenitors, thus re-
quiring colonization by extrinsic progenitors. The omentum
and spleen are associated with the stomach mesoderm and
endoderm. Actually, omentum and spleen anlage belong
primitively to the P-Sp, raising the possibility that hemo-
poiesis detected in these organs derives from in situ–gener-
ated progenitors. The extrinsic origin of splenic hemopoietic
progenitors in the spleen has been documented in the chick
embryo through parabiosis experiments (12) and transplanta-
tion assays (13). In the mouse, hemopoiesis in the splenic ru-
diment is also thought to result from colonization, but the
evidence is descriptive (14).
 
 
 
In the spleen, hemopoietic ac-
tivity has been documented from 16–17 dpc (14) until about
the first week of postnatal life. B cell precursors have been
detected in the omentum by 14 dpc (15–17).
As no data are available about early hemopoiesis in the
omentum, and information in the case of the spleen is
scarce, we analyzed these two sites for their ability (or in-
ability) to generate HSCs, on the one hand, and to sustain
hemopoiesis, on the other. Both organs were unable to
generate hemopoietic progenitors when separated from the
embryo before 12 dpc, even if precultured before dissocia-
tion, a method that had permitted the detection of progen-
itor emergence in the presomitic embryonic compartment
(4). We report that the spleen is colonized after day 12 of ges-
tation by extrinsic multipotent progenitors, most likely AGM
derived. The splenic environment sustains self-renewal of
HSCs and differentiation of their progeny, as determined by
the presence of long-term reconstituting (LTR) progenitors
and by the increasing number of lymphoid and erythromy-
eloid colony-forming cells (CFCs) with the developmental
stage. In contrast, after colonization at 14.5 dpc, the omen-
tum environment is shown to provide for the survival of lim-
ited numbers of lymphocyte precursors. The absence of both
erythromyeloid CFCs and LTR activity indicates that the
omentum is not a hemopoietic organ. This study, together
with previously reported results, indicates that all analyzed he-
mopoietic organs (fetal liver, thymus, spleen, and bone mar-
row) and the omentum are colonized tissues. In the murine
model, P-Sp/AGM-derived HSCs might thus constitute the
only pool of HSCs produced de novo within the embryo.
 
Materials and Methods
 
Mice and Cell Preparations
 
The following mouse strains were used in the course of this
study. BALB/c mice provided embryos for precursor numeration.
The differentiation potential analysis and the cell fractionation
were performed using embryos from the two C57BL/6 congenic
lines bearing the Ly5.2 and Ly5.1 alleles of the panhemopoietic
marker CD45. F1 embryos resulting from the cross of the two
C57BL/6 lines were also used.
Mature females were caged with breeding males. The day of
vaginal plug observation was considered as 0.5 dpc. Pregnant fe-
males between 9.5 and 15.5 dpc were killed by cervical disloca-
tion. Embryos were staged by somite counting and/or by devel-
opment of the limb buds. The various rudiments were dissected
under a stereomicroscope, and single cell suspensions were pre-
pared by passage of the selected tissues through a 26-gauge nee-
dle. Viable cells were counted by trypan blue exclusion.
 
Basic Culture Conditions
 
The basic conditions were described previously (18, 19). Cells
were cultured on the S17 stromal line (a gift from K. Dorshkind,
University of California at Riverside, Riverside, CA) with the fol-
lowing cytokines: IL-7 at 50–100 U/ml was provided by the su-
pernatant of a stably transfected cell line (from Fritz Melchers, Basel
Institute for Immunology, Basel, Switzerland), and c-Kit ligand
(KL; Genetics Institute) was used at a 1:500 dilution, which allows
the emergence of mast cells from adult bone marrow.
Cells were seeded at limiting dilution or micromanipulated, then
plated in 48–96 wells from 96-well plates for each cell concentra-
tion, in culture medium (OptiMEM [GIBCO BRL] plus 10%
FCS) supplemented with IL-7 and KL. At day 10 of culture, cells
from individual wells were harvested and divided into three frac-
tions. Each fraction was transferred to culture conditions that pro-
mote erythromyeloid, lymphoid B, or lymphoid T differentiation.
 
Erythromyeloid Conditions.
 
Cells were cultured on S17 stromal
cells (known to produce GM- and M-CSF) in the presence of KL,
human recombinant erythropoietin (Epo, 4 U/ml; a gift of E. Gold-
wasser, University of Chicago, Chicago, IL), GM-CSF at 4 ng/ml,
and IL-3 (supernatant from a transfected cell line from F. Melchers),
used at a 1:100 dilution. Cells retrieved from the culture were ana-
lyzed for Gr-1 and Ter-119 expression as well as by Giemsa staining.
 
B Lymphoid Conditions.
 
Cells were cultured on S17 stromal
cells with medium supplemented only with IL-7. For analysis of
mature B cells, cells were stimulated with LPS (
 
Salmonella typhosa
 
W0901; Difco) as described previously (20), and Ig secretion was
detected in an ELISA.
 
T Lymphoid Conditions.
 
The third fraction was placed in fetal
thymic organ cultures (FTOCs [21]) using recipient thymic lobes
from 14–15-dpc Ly5 congenic C57BL/6 mice bearing a Ly5 al-
lele differing from that of donor cells, as described previously (5).
In brief, 30 
 
m
 
l of the cell suspension was distributed between
three and four irradiated fetal thymic lobes in wells of a Terasaki
plate and cultivated in a hanging drop for 24–48 h. Colonized
thymic lobes were cultured for 10–13 d on polycarbonate filters
(0.8 
 
m
 
m; Millipore) floating on top of the culture medium. To
analyze cells from repopulated thymuses, single cell suspensions
were made by teasing the organs with two needles. The cells ob-
tained from three to four thymic lobes repopulated with cells
from the same clone were pooled for flow cytometry analysis. To
calculate the frequency of T cell precursors in the omentum, we
colonized each of 10–15 irradiated thymic lobes with a constant
number of cells. Three different cell concentrations were used. 12 d
later, individual lobes were teased, and cells were analyzed by
flow cytometry. The frequency of T cell precursors was then cal-
culated by a Poisson distribution analysis.
 
Organotypic Culture
 
Explanted tissues were placed directly on a polycarbonate filter
as described above, except that 5 
 
3 
 
10
 
2
 
5
 
 M 
 
b
 
-ME was included 
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in the culture medium. After 10 d of culture, the explants were
mechanically dissociated before flow cytometry analysis.
 
In Vitro Colony Assay
 
AGM (10.5–11.5 dpc), omentum, and spleen (11–15.5 dpc)
were dissected and dissociated. 5 
 
3
 
 10
 
3 
 
or 5 
 
3
 
 10
 
4 
 
cells from
each sample were mixed with OptiMEM, 0.8% methylcellulose
(15 mPAS; Fluka), and 10% FCS, supplemented with IL-11, KL,
IL-3, GM-CSF, and Epo.
Colonies were scored at day 3 (CFU-E) and day 7 (burst-
forming units–erythroid [BFU-E] and CFC-Mix [see below]).
Colonies of well-hemoglobinized clusters of 
 
,
 
100 cells were
classified as CFU-E. Large colonies of red cells (
 
.
 
300 cells) were
counted as BFU-E, while colonies containing at least 2 myeloid
cell types and erythroid cells were classified as CFC-Mix.
 
In Vivo Reconstitution Experiments
 
To test for LTR potential, cells from 13–14.5-dpc C57BL/6
embryo omentum and spleen were injected in the retroorbital si-
nus of lethally irradiated (800–850 rad) C57BL/6 mice bearing an
Ly5 allele differing from donor embryos. The mice received in
addition 5 
 
3
 
 10
 
5
 
 adult bone marrow cells bearing the same Ly5
allele as the recipient. Control mice were injected with PBS. Af-
ter 6–8 mo, the recipient mice were killed; the bone marrow,
spleen, thymus, and cells from the peritoneal cavity (PeC) were
then collected and analyzed by flow cytometry.
 
Flow Cytometry Analysis
 
Flow cytometry analysis was performed in a FACScan
 
®
 
 with
the CellQuest program (Becton Dickinson). The Ly5 alleles were
characterized using biotinylated or fluorescein-conjugated anti-
bodies purified from the supernatant of the 104.2 (anti-Ly5.2) or
A20.17 (anti-Ly5.1) hybridoma lines. The following antibodies
were used to label B and T lymphocytes: anti-CD45R/B220
(clone RA3-6B2), anti-CD4 (L3T4), all directly coupled to PE,
anti-CD8 (Ly-2) coupled to FITC, and biotinylated CD5. PE-
conjugated Gr-1 and biotinylated Ter-119 were used to charac-
terize cells from the myeloid and erythroid lineages, respectively.
All antibodies were from PharMingen. Streptavidin-Tricolor (Cal-
tag) was used as a second step reagent. In all analyses, propidium
iodide was used to exclude dead cells.
 
Results
 
Hemopoietic Progenitors Are Generated in the P-Sp/AGM from
8.5 to 12.5 dpc.
 
We have previously shown that multi-
potent hemopoietic progenitors are detected in the P-Sp
region starting at the stage of 10 somites (8.5 dpc) and in-
crease thereafter, reaching 15 detected progenitors per ex-
plant at the 25-somite stage (9.5–10 dpc [5]). This region
has been called the AGM region after 9.5 dpc, and has been
shown to harbor HSCs (6, 7). However, the numbers of
generated hemopoietic cells in this region and the duration
of the process have been important missing information.
Here, we approached these questions by performing a stage
by stage quantitative analysis of progenitors capable of gen-
erating B lymphocytes in the AGM region over a period of
time extending from 9.5 to 13 dpc. Limiting dilution tests
were done under in vitro conditions that support the gen-
eration of B cells from multipotent progenitors. Approxi-
mately 20 progenitors were detected per AGM at 9.5 dpc
(25 somites; Fig. 1). This number increased to a maximum
of 100 between 10.5 and 11.5 dpc (35–45 somites), as fetal
liver hemopoietic activity began. A large variation between
embryos was observed between the 25- and 45-somite
stages. Thereafter, progenitors dramatically decreased to a
barely detectable number by 12.5 dpc.
These experiments, with previous studies (5), indicate
that the P-Sp/AGM region is continuously active as a site
of hemopoietic cell generation from days 8.5–12.5 of
mouse gestation. The maximum activity was detected be-
tween 10.5 and 11 dpc, coinciding with the period of fetal
liver and thymus colonization. At 13 dpc, hemopoietic
generation in the P-Sp/AGM region became extinguished.
 
Within the AGM, Hemopoietic Progenitors Are Concentrated
in the Aorta.
 
In an attempt to precisely determine the dis-
tribution of hemopoietic progenitors within the AGM, we
further dissected this region into its various components
(Fig. 2 A–C): the aortic endothelium and its wall, sur-
rounded by mesenchymal cells; the mesonephros, includ-
ing the Wolffian duct with adjacent mesonephretic cells; the
genital ridges; and the mesentery lying ventrally to the
aorta, from which the developing gut had been removed. B
cell progenitors within each of these regions were again
quantified.
Due to the minute amount of material in the various ex-
plants, cross-contamination between the different compo-
nents of the AGM could not be avoided. Nevertheless, the
results of two experiments (Table I) carried out at the 30–
35- and 35–40-somite stages, when the precursor content
in the AGM reaches a peak, indicate that the aorta is highly
enriched in these progenitors. At this stage, and without
any cell purification, the frequency of hemopoietic clones
in the aorta was 1:12. At the time when the number of
progenitors per AGM began to decrease, the aorta sepa-
rated from the other components of the AGM gave rise to
similar numbers of lymphocyte clones as the whole unsepa-
rated region (Fig. 1). The mesonephros repeatedly dis-
played the lowest number of progenitors. As for the gonads
and the mesentery, the precursor content was more vari-
Figure 1. Evolution of absolute numbers of B cell progenitors detected
per AGM over the midgestation period. Progenitors endowed with B
lymphoid potential were quantified through limiting dilution analysis. 
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able, possibly depending on the degree of contamination
by cells from the region underlying the aorta (Table I).
In a similar experiment performed at the 50–55-somite
stage (12.5 dpc), when progenitors in the AGM were dis-
appearing, all remaining progenitors were located in the
aorta and the surrounding tissue (data not shown).
The distribution of progenitors along the antero-poste-
rior axis was also tested in a similar way, in two indepen-
dent experiments. The AGM explant was divided into two
(Table I) or three sections (data not shown). Although the
total number of progenitors predominated in the anterior
region located immediately below the fetal liver, their fre-
quency was higher in the intermediate and caudal regions.
In conclusion, hemopoietic progenitors in the AGM were
virtually absent from the most lateral components of the
AGM (mesonephros and gonads), and more than half of
these progenitors were concentrated in the aorta region.
 
AGM Is Not a Site of Ongoing Hemopoiesis.
 
Although the
environment of the P-Sp/AGM region is specifically generat-
ing hemopoietic cells de novo, it is unclear whether lineage
commitment also occurs there. We analyzed the capacity of
the progeny of micromanipulated individual cells to differ-
entiate into erythromyeloid and lymphoid cells when seeded
in culture conditions promoting colony formation from
BFU-E, CFU-E, and CFC-Mix. We chose to enrich he-
mopoietic progenitors based on the expression of antigens
defining populations comprising LTR HSCs, either in the
fetal liver (AA4.1 [22]) or in adult bone marrow (Sca-1 [23]).
After a period of expansion, the progeny of individual
cells previously enriched for AA4.1 expression was tested for
the capacity to generate B or T lymphoid as well as erythro-
myeloid precursors (5; see also Materials and Methods). Ta-
ble II shows the number of multipotent clones found at the
various stages analyzed. These numbers mostly correlate with
those of B cell precursors detected previously (compare Fig. 1
and Table II, top). Fig. 3 shows the flow cytometric profiles
of the progeny of one representative micromanipulated pre-
cursor. After FTOC (top panel), single- and double-posi-
tive CD4/CD8 thymocytes expressing intermediate and high
levels of TCR-
 
a
 
/
 
b
 
 were present in the reconstituted lobes.
B lineage cells developed in culture on stromal cells with
IL-7 (bottom panel) and, further stimulated by LPS, were
shown to secrete immunoglobulins. May-Grünwald Giemsa
staining of precursors from the same progenitor expanded
with KL, GM-CSF, IL-3, and Epo showed the develop-
ment of multilineage myeloid cells (data not shown).
The experiment performed at the 50–55S stage (repre-
senting a pool of 24 AGMs) yielded 27 colonies, a value
Figure 2. Structure and dissection of the AGM. (A) Scanning electron
microscopy of a partially dissected AGM (bar, 0.22 mm). (B) Scanning
electron microscopy of an explanted AGM. The anterior part of the ex-
plant (left) is considerably larger than the caudal part (bar, 1 mm). (C)
Semithin section of an AGM explant. Note the hemopoietic cell cluster
(reference 27) associated with the endothelium of the ventral part of the
aorta (arrow; bar, 0.26 mm). Ao, aorta; GR, genital ridges; Mn, meso-
nephros; Mt, mesentery; SV, subcardinal vein; WD, Wolffian duct.
 
Table I.
 
Distribution of Hemopoietic Progenitors within the AGM
 
Tissue
30–35 somites 35–40 somites
Frequency
Precursors/
organ Frequency
Precursors/
organ
Mesonephros 1/150 9 (9.89%) 1/1,000
 
,
 
0.1 (0%)
Mesentery 1/90 28 (30.77%) 1/75 17 (20.48%)
Gonad 1/400 4 (4.39%) 1/16 14 (16.86%)
Aorta 1/35 50 (54.94%) 1/12 50 (62.65%)
Anterior 1/100 100 ND
Caudal 1/65 49 ND
AGM was further dissected into its various components or, alterna-
tively, into anterior and posterior regions. After dissociation, precursor
numbers in each component were evaluated through limiting dilution
analysis. 
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larger than that obtained during precursor numeration
through limiting dilution (5–20; Fig. 1 and Table II). This
discrepancy may either reflect individual variations or may
be due to the use of a majority of AGMs close to the 50S
stage in the cloning experiment.
Enrichment for cells expressing the AA4.1 marker al-
lowed recovery of the majority of the multipotent cells.
When the AA4.1
 
2
 
 fraction was tested, no multipotent pre-
cursor was detected in 200 cells plated (data not shown). Im-
portantly, all progenitors with lymphoid potential analyzed
also had erythromyeloid potential, suggesting their multipo-
tentiality. The rare macrophage colonies observed are likely
to derive from blood contamination. The highest frequency of
multipotent clones was found in 35–45S AGM when one out
of four plated cells could differentiate in both a lymphocyte
and a myeloid progeny. Considering that cell separation by
panning also enriches for nonspecific adherent cells, the fre-
quencies obtained could well represent one out of one he-
mopoietic progenitor differentiating
 
 
 
in vitro. We then dis-
sected the aorta and attempted to enrich hemopoietic cells
using two different hemopoietic markers (Table II, bottom).
AA4.1-expressing cells were highly enriched for multipotent
progenitors, as previously shown for the whole AGM; in con-
trast, Sca-1 enrichment resulted in recovery of few multipo-
tent progenitors, indicating either low levels or heterogeneous
expression of this surface marker in the AGM population.
As shown above, most progenitors in the AGM were
multipotent cells also capable of generating erythromyeloid
progeny after in vitro expansion on stromal cells. However,
it could be conceived that myeloid differentiation occurs in
situ. To test this possibility, AGMs were dissociated upon
explantation, and erythromyeloid colony assays were per-
formed immediately. Circulating blood cells were used as
positive control and cells dissociated from the developing
limb buds as negative control. In this rudiment, we ex-
pected to detect only circulating precursors trapped in the
blood vessels. The results displayed in Table III show the
number of colonies per explant and/or blood obtained from
one embryo. Committed erythroid progenitors such as
CFU-E and BFU-E were fewer in the AGM than in the
limb bud. However, the numbers of mixed colonies were
similar to the number of B lymphoid progenitors previ-
ously found (compare Table III and Fig. 1) and consistently
higher than in the limb bud, suggesting that they represent
the progeny of the AGM multipotent cells.
 
Development of the Omentum and Spleen.
 
The omentum
rudiment becomes first identifiable at 10.5 dpc as a thick
 
Table II.
 
Differentiation Potential of Single AA4.1
 
1
 
 or Sca-1
 
1
 
 
Cells from the AGM or the Aorta
 
Stage
(no. of somites) Percent total cells
Cloning
efficiency
Multipotent
clones/organ
AGM
30–35 0.3% AA4.1
 
1
 
1/6 24
35–45 ND 1/4 50
50–55 ND 1/21 27
Aorta
48–52 3.25% AA4.1
 
1
 
1/4 65
48–52 2.5% Sca-1
 
1
 
1/33 6
Clones generated from individual micromanipulated cells were fraction-
ated and further cultured in conditions promoting erythroid, myeloid,
and lymphoid B and T lineages. Clones were considered multipotent
when they gave rise to both lymphoid and myeloid derivatives. All clones
that generated lymphocytes also gave rise to multiple myeloid progeny.
The clones that only gave rise to single myeloid progeny (typically mac-
rophages) were not taken into account. The ratio between growing
clones and the number of cells plated defines cloning efficiency. In all ex-
periments, cells were plated at 0.5 cell per well or micromanipulated.
Figure 3. Flow cytometry pro-
file showing the lymphoid prog-
eny of a single micromanipulated
AGM cell. (Top) After culture in
T lymphoid conditions. Cells of
donor origin were gated as
Ly5.12. (Bottom) After culture in
B lymphoid conditions. Lympho-
cytes were gated on forward and
side scatter.
 
Table III.
 
Quantification of Erythromyeloid Progenitors
in the AGM
 
AGM Blood Limb bud
10.5 dpc 11.5 dpc 11.5 dpc 11.5 dpc
CFU-E 17 3 515 8
BFU-E 40 32 8,620 62
CFC-Mix 65 48 43 3
Cells from AGM, peripheral blood (positive control), and dissociated
limb buds (negative control) were plated in methylcellulose under con-
ditions that support multilineage erythromyeloid colony formation.
CFU-E were counted on day 3, BFU-E and CFC-Mix on day 7 of
culture. 
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mesodermal layer covering the enlarged gut pocket that
will give rise to the stomach. As development proceeds,
this layer becomes thinner and vascularized. At 12 dpc, the
spleen rudiment develops inside the omentum as two
thickenings extending diagonally from the lower left and
the upper right side to the middle of the stomach. The
splenic rudiment is soon distinguishable from the remain-
der of the omentum by an increasing number of bright red
spots, a sign of active erythrocyte accumulation. At 13.5
dpc, the rudiment has acquired the elongate shape typical
of mouse (Fig. 4). Up to 12 dpc, the omental rudiment, in-
cluding the developing spleen, was analyzed as a whole in
our various experiments. As soon as the spleen rudiment
could be accurately identified within the omentum, both
rudiments were dissected and the progenitor potentials
were assessed separately.
Lymphoid cells have been identified in the embryonic
omentum at 14.5 dpc
 
 
 
(15, 16). However, their origin and
differentiation potential are as yet unknown. To investigate
the ability of the omentum to generate hemopoietic cells,
the early rudiments were cultured organotypically, before the
quantification of progenitors. The differentiation potential
was then assessed through in vitro colony assay and in vivo
reconstitution of irradiated adults. This procedure was ap-
plied beginning at early developmental stages, from 11 to
15.5 dpc.
 
Contrary to the Spleen, the Omentum, although Harboring
Lymphoid Precursors, Does Not Carry Out Hemopoiesis.
 
B cell
progenitors, CFU-E and CFC-Mix, were numbered be-
tween 11 and 15.5 dpc (five separate experiments; Fig. 5).
At 11–12 dpc, when the spleen rudiment cannot be distin-
guished from the omentum, cells isolated from the omen-
tum and spleen yielded a few myeloid colonies comparable
to that from nonhemopoietic tissues (limb bud), likely trapped
from the systemic circulation, with less than one B cell pro-
genitor per omental and splenic rudiment. At 13 dpc, the
omentum and spleen each yielded less than five progenitors
endowed with B lymphoid potential. During the subse-
quent developmental stages, the frequency of these precur-
sors remained constant in the omentum (3–10 per organ),
whereas in the spleen their number increased regularly and
reached 
 
.
 
1,000 progenitors per spleen at 15.5 dpc, the lat-
est stage analyzed. In the case of myeloid precursors, whose
frequency in the blood declines rapidly, the omentum that
contained rare CFU-E and CFC-Mix at 12–13 dpc com-
pletely lacked all types of colony-forming progenitors
thereafter, confirming that the rare myeloid colonies found
at 11.5–12 dpc derived from precursors present in the cir-
culation. In contrast, increasing numbers of progenitors were
present in the spleen rudiment (Fig. 5).
When limiting numbers of 14–15-dpc omentum cells
were allowed to repopulate irradiated fetal thymic lobes, a
frequency of 1 out of 3,000 T cell precursors was found,
representing 4 precursors per omentum (data not shown).
Figure 4. Anatomical relationship between omentum and spleen. The
omentum and spleen explanted from a 14.5-dpc embryo are shown after
being removed from the underlying stomach. The pancreas is then dis-
sected out, and the two organs are separated (bar, 0.5 mm). Omentum,
arrowheads; Sp, spleen; P, pancreas.
Figure 5. Quantification of erythromyeloid precursors CFU-E, CFC-
Mix, and B lymphoid precursors in omentum and spleen over the mid-
gestation period. Ovals, explant comprising both the omental and splenic
rudiments (before 13 dpc); circles, splenic explant; squares, omental explant. 
49
 
Godin et al.
 
It has previously been stated that the murine splenic ru-
diment is colonized by 15 dpc
 
 
 
(14). The results described
above indicate that both omentum and spleen contain hemo-
poietic progenitors from 14.5 dpc. However, none of the
experiments allowed us to discriminate whether the pro-
genitors detected were generated in situ or were seeded from
the circulation. Therefore, we introduced an organ culture
step to discriminate between these two possibilities. As stated
above, this culture step allows the emergence of HSCs in
structures isolated from the embryos before this event nor-
mally takes place (4). Explants isolated from embryos at 11
and 12 dpc (38–50S) comprised both rudiments, whereas at
12.5 and 13.5 dpc the spleen and omentum were separated.
Fig. 6 shows the flow cytometric profiles of cells dissociated
from individual explants after 12 d in culture and stained
with antibodies recognizing CD45 and CD19, a B lineage–
specific marker. At 12.5 and 13.5 dpc, all splenic explants
analyzed contained a large fraction of cells of the B lineage,
whereas they were completely absent from the omentum
explants. At earlier stages, 19 out of 25 explants analyzed
were completely negative for CD19
 
1
 
 cells, showing that
hemopoietic cells observed later do not originate in situ. 6
out of 25 explants did show a low representation of CD19
 
1
 
cells, indicating that the process of colonization might al-
ready have started in a few cases.
We also tested the presence of LTR HSCs in the omen-
tum and spleen, i.e., cells isolated from both organs were
used to reconstitute the hemopoietic system of lethally irra-
diated mice, for 
 
.
 
6 mo. 14.5-dpc embryos were chosen as
donors, since in vitro quantification of B cell progenitors
 
showed that this is the earliest stage at which progenitors
are present in significant numbers in both organs.
Omentum and spleen were explanted from 14.5-dpc
embryos bearing the Ly5.2 allele of the CD45 antigen.
Cells suspensions from two to four omenta, or one to three
spleen equivalents, were injected intravenously per recipi-
ent into lethally irradiated Ly5.1 mice, together with 5 
 
3
 
10
 
5
 
 syngeneic bone marrow cells (Ly5.1). After 6–8 mo, the
contribution to hemopoiesis of donor-derived cells was an-
alyzed by flow cytometry in the bone marrow, thymus,
spleen, and PeC, and results are shown in Table IV.
None of the six mice grafted with omentum harbored
donor-derived cells, indicating that undetectable numbers
of hemopoietic stem cells are present in this organ. In con-
trast, 4 out of the 11 mice injected with embryonic spleen
cells showed long-term multilineage reconstitution from
donor-derived cells, albeit with low contribution in 2 cases.
Altogether, these results show that the splenic rudiment
is colonized by 12.5 dpc and actively starts its hemopoietic
activity around day 14.5 of gestation. At this stage, LTR
activity is readily detected, suggesting that the spleen is col-
onized by stem cells. In contrast, the omentum harbors a
limited number of committed lymphoid precursors that do
not significantly expand with time.
 
Discussion
 
Fetal liver and thymus are the major lymphohemopoietic
organs during mouse embryonic development. The ab-
sence of hemopoiesis in organ cultures of both rudiments
Figure 6. Flow cytometry
profile showing CD19 (FL1) and
Ly5 (FL3) staining of explanted
omental-splenic rudiments (11
and 12 dpc), omenta, or spleens
(12.5 and 13.5 dpc), after 12 d of
organotypic culture. Lympho-
cytes were gated on forward and
side scatter. The ratio of explants
containing CD191 cells appears
above the corresponding profile. 
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(1–3), isolated early in ontogeny, showed that hemopoietic
cell generation does not occur
 
 
 
in situ. In addition, in the
avian model, transplantation of early spleen and thymus ru-
diments showed absence of donor-derived progenitors and
colonization by extrinsic progenitors (13, 24). Together,
these results established that hemopoietic progenitors de-
veloping in the major hemopoietic organs are not gener-
ated
 
 
 
in situ. This is also true of the bone marrow, the main
hemopoietic organ in adult mammals, which is thought to
be colonized by stem cells of fetal liver origin.
We and others have previously shown that intraembry-
onic candidate progenitors responsible for the establish-
ment of definitive hemopoiesis are present in the mouse in
the P-Sp at 8.5–10 dpc (4, 5) and in the AGM at 10.5–11
dpc (6, 7). Although AGM progenitors display LTR activ-
ity in adult recipients (6), those found in P-Sp are capable
of reconstituting only newborn recipients after intraliver
injection (25). These results indicate that either competi-
tive reconstituting ability or homing properties of the intra-
embryonic progenitors differ at these two different stages.
Arguments favoring a continuous generation of hemopoie-
tic progenitors in the P-Sp and AGM are based on the fact
that both sites represent the same anatomical structure at
two distinct developmental stages. Moreover, intraembry-
onic hemogenic potential is, at these stages, restricted to
these sites.
By quantifying in vitro progenitors in the AGM, we show
here that the number of progenitors in the P-Sp/AGM in-
creases regularly, suggesting that the process of generation
and/or amplification of progenitors, as well as their release
into the blood stream (8), is continuous. The in vitro be-
havior of AGM progenitors is identical to that of P-Sp pro-
genitors (5). P-Sp/AGM progenitors are both enriched in
populations expressing the AA4.1, rather than the Sca-1,
antigen. More importantly, progenitors isolated from both
sites remain multipotent, as shown by single cell fate analy-
sis. The AGM is a site where no active hemopoiesis takes
place, as shown by the absence of lineage-restricted erythro-
myeloid colonies. We were consistently unable to detect
committed erythromyeloid precursors above levels detected
in our negative control, showing that the evolution to that
stage does not occur within the AGM. Our unpublished
results (Manaia, A., and I. Godin) point to a similar behav-
ior in the P-Sp at earlier stages. Consistent with this result,
single micromanipulated cells were capable of giving rise to
erythroid, myeloid, and lymphoid progenitors when cultured
on the stromal cell layer, reinforcing the notion that AGM
is not a site where hemopoietic differentiation occurs. Thus,
the population of hemopoietic progenitors that emerges in
the AGM and reaches its maximum size at 11 dpc, before
entering the circulation, constitutes a candidate for a pure
stem cell pool.
We favor the view that hemopoietic progenitors in the
P-Sp and AGM are the product of one single and continu-
ous generation process. However, their capacity to recon-
stitute hemopoiesis in adult recipients changes with time.
We hypothesize that the first multipotent cells released in
circulation between 9 and 10 dpc do not yet have the full
array of properties necessary to colonize hemopoietic organs
(4, 6). As mentioned above, thymus and fetal liver are colo-
nized starting at 10–11 dpc. At this stage, AGM progenitors
are already capable of LTR activity in adult recipients (6),
and might be the first colonizing cells in vivo.
Finally, the subdivision of the AGM into various com-
ponents allowed us to allocate the progenitors to the aorta
and surrounding region. This restriction to the aorta in-
creases as development proceeds (55% at 30–35S, 62% at
35–40S, and 100% at 12–13 dpc). These experimental data
may reflect improved accuracy in tissue separation, since
the organ boundaries are better defined as development
progresses. Alternatively, it might reflect an active displace-
ment of cells into the lumen of the aorta from where they
migrate to colonize the hemopoietic organs (8). Previous in
situ analyses aimed at localizing intraembryonic hemogenic
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LTR Assays
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Embryo equivalent
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Ly5.1 mice were irradiated and injected with 14.5-dpc Ly5.2 spleen or omentum together with syngeneic bone marrow cells. Mice were analyzed
6–8 mo later. Shown are the percentages of donor-derived cells in the analyzed hemopoietic organs. The degree of reconstitution was measured af-
ter staining cells from different organs with Gr-1, B220, CD4 and CD8, and Ly5.2 mAbs.51 Godin et al.
sites already pointed to the aorta, as clusters of cells local-
ized in the ventral wall of this vessel (Fig. 2 C) specifically
express markers for early hemopoietic cells (26–28).
Based on the expression of b-gal in the mesonephros of
Ly6E.1-lacZ transgenic mice, Miles et al. (29) concluded
that the mesonephros was the major site of hemopoietic
production in the AGM. Here, we find that the mesoneph-
ros is consistently devoid of hemopoietic progenitors. It is
possible that Sca-1 was detected in cell types other than he-
mopoietic progenitors, since in the adult, Sca-1 is expressed
in various nonhemopoietic cell types, including the kidney
epithelium (30, 31). Moreover, cell separation experiments
indicate that AGM progenitors are more efficiently en-
riched using the expression of the AA4.1 antigen than with
Sca-1. As shown previously (32), the Sca-1 antigen is sig-
nificantly expressed in the AGM and fetal liver only after
11 dpc. As reported previously (7), we found progenitors
along the entire length of the AGM, but their number is
higher in the anterior part.
To determine whether indeed de novo hemopoietic
generation and hemopoietic differentiation are two incom-
patible properties always occurring in independent in-
traembryonic locations, we analyzed the omentum and
spleen for the capacity to generate hemopoietic cells. We
cultured the early rudiments in vitro in organ culture con-
ditions, a method previously shown to permit the emer-
gence of hemopoietic progenitors in a site that does not
harbor hemopoietic progenitors at the time of explantation
(4). Both organ culture and limiting dilution analysis indi-
cate that, before 12.5 dpc, most omentum-splenic rudi-
ments yielded no hemopoietic progeny, excluding an in
situ generation of hemopoietic cells.
The spleen contains the first detectable lymphomyeloid
progenitors at 12.5 dpc, consistent with previous findings
in both mice (14) and chickens at an equivalent stage (13).
We have previously shown that, before day 13 of gestation,
all circulating progenitors with lymphoid potential are multi-
potent cells (8). Therefore, we conclude that the spleen is
colonized by multipotent progenitors, originating in the
P-Sp/AGM. This conclusion is confirmed by our results
showing LTR activity in the spleen 1 d later. The exponen-
tial increase in colony-forming progenitors between days
14 and 15.5 of gestation points to 14.5 dpc as the beginning
of hemopoietic activity in the spleen.
The omentum harbors a constantly low number of B
and T cell precursors (z10, from 13–15.5 dpc) and consis-
tently lacks erythromyeloid CFCs throughout this period.
In addition, we failed to detect LTR activity in the omen-
tum rudiment even when cells pooled from four structures
were injected into a single recipient. We conclude that this
site is colonized by committed lymphoid progenitors, be-
tween 14 and 15 dpc, and that no expansion occurs in situ,
as shown by both in vitro colony numeration and organo-
typic culture.
A picture emerges from this and previous studies indicating
that hemopoietic progenitors can be obtained from 7.5-dpc
organ-cultured intraembryonic splanchnopleura. The first
progenitors that can differentiate into all hemopoietic lin-
eages, when the intraembryonic splanchnopleura is immedi-
ately dissociated into single cells, are found at 8.5 dpc. These
cells are very few and, although multipotent, have poor re-
constituting activity. Thereafter, their numbers increase, and
they progressively acquire LTR activity (10.5–11 dpc) when
transplanted into an irradiated adult recipient, 1 d earlier
than the fetal liver (11.5–12 dpc). The consistent absence of
signs of hemopoietic differentiation in the P-Sp/AGM and,
conversely, the incapacity of hemopoietic organs to gener-
ate de novo hemopoietic progenitors show that both activ-
ities are environmentally incompatible. Considering the tim-
ing of adult LTR activity as a landmark and the consecutive
appearance of this activity in the AGM and fetal liver, it is
reasonable to conclude that AGM progenitors home to the
fetal liver. The extinction of hemopoietic cell generation in
the AGM by 12.5 dpc and the failure to detect this activity
elsewhere indicate that P-Sp/AGM progenitors are the
only HSCs generated de novo. Although exact estimations
are difficult, the total number of intraembryonic HSCs
generated in the mouse should not exceed 500 cells, as cal-
culated from results shown in Fig. 1. This initial pool of
stem cells will further expand (self-renewal) in the primary
hemopoietic organs throughout life.
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